Platform
Features
ZeaKal
Contact
Mary is the Director on the investment team at RIV Capital, an investment and acquisition company specializing in cannabis and hemp. Her expertise covers the life sciences and agri-technology fields.
9 members
Centogene
Abveris
Genentech
IFM Therapeutics
Wake Forest Innovations